$12.230
+0.131 (+1.07%)Al cierre
Rentabilidad y márgenes de CLBT
Evaluating the bottom line, Cellebrite DI Ltd maintains a gross margin of 80.78%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.82%, while the net margin is 4.86%. These profitability ratios, combined with a Return on Equity (ROE) of 12.31%, provide a clear picture of how effectively CLBT converts its operational activities into shareholder value.
Comparativa sectorial de CLBT
In the context of the broader market, CLBT competes directly with industry leaders such as VIA and ALRM. With a market capitalization of $2.83B, it holds a significant position in the sector. When comparing efficiency, CLBT's gross margin of 80.78% stands against VIA's 39.63% and ALRM's 62.33%. Such benchmarking helps identify whether Cellebrite DI Ltd is trading at a premium or discount relative to its financial performance.
Desempeño financiero de Cellebrite DI Ltd
Cellebrite has shown strong revenue growth with Q2 2026 revenue at $131 million, a 16% increase year-over-year. However, net income has declined significantly, with Q2 2026 net income at $6.37 million, down from $20.7 million in Q4 2025.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.